Press release – No. 19 / 2026 Zealand Pharma announces opening of new Research Hub in Cambridge, Massachusetts Builds on the Metabolic Frontier 2030 strategy, advancing its ambition to become a leader in obesity and metabolic health Ribbon-cutting ceremony marks the official opening of the Company's primary U.S. address, expanding Zealand Pharma's global research platform Copenhagen, Denmark, and Boston, Massachusetts, September 30, 2026 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no.
